IPRO QIN-QIO Resource Library

This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016 (MMWR Recomm Rep 2016;65[No. RR-1]:1–49) and includes recommendations for managing acute (duration of <1 month), subacute (duration of 1–3 months), and chronic (duration of >3 months) pain.

The recommendations do not apply to pain related to sickle cell disease or cancer or to patients receiving palliative or end-of-life care.

The guideline addresses the following four areas:

1) determining whether or not to initiate opioids for pain,

2) selecting opioids and determining opioid dosages,

3) deciding duration of initial opioid prescription and conducting follow-up, and

4) assessing risk and addressing potential harms of opioid use.

CDC developed the guideline using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework. Recommendations are based on systematic reviews of the scientific evidence and reflect considerations of benefits and harms, patient and clinician values and preferences, and resource allocation.

CDC obtained input from the Board of Scientific Counselors of the National Center for Injury Prevention and Control (a federally chartered advisory committee), the public, and peer reviewers.

CDC recommends that persons with pain receive appropriate pain treatment, with careful consideration of the benefits and risks of all treatment options in the context of the patient’s circumstances.

CDC Project Firstline

Adopt Project Firstline

Project Firstline helps healthcare workers understand, think critically, and apply infection control actions.

Project Firstline offers easy-to-use, accurate, and free infection control training resources in multiple formats to align with healthcare workers’ learning needs and preferences. This tool can help you achieve success in providing staff with consistent and effective education related to infection prevention and control, which was developed by the Centers for Disease Control (CDC).

 IPRO QIN QIO nursing home team recommends that you consider using these resources in a structured way or as a “just in time” learning opportunity.

CDC’s 2022 Clinical Practice Guideline for Prescribing Opioids Training

This training highlights the 12 recommendations and information on implementation and includes patient scenarios.

Physicians, nurses, and other health professionals can receive free continuing education for this training by registering on CDC TRAIN. Search for course number WB4701 and complete the evaluation. WB4701 Accreditation Statement

Training: CDC’s 2022 Clinical Practice Guideline for Prescribing Opioids for Pain

Highlights the 12 recommendations and information on implementation and includes patient scenarios.

Physicians, nurses, and other health professionals can receive free continuing education for this training by registering on CDC TRAIN. Search for course number WB4701 and complete the evaluation. WB4701 Accreditation Statement

Training: CDC’s 2022 Clinical Practice Guideline for Prescribing Opioids for Pain

CDC developed trainings to assist clinicians and other healthcare personnel to provide patient-centered care. Trainings are offered as full or mini modules and patient cases. Many of the trainings offer continuing education (CE); please choose the trainings that best meets your needs.

An easy checklist for use in nursing homes when a new positive case of COVID-19 is identified. The checklist addresses area set up, staffing, supplies, notifications and more.

Webpage to access the web-based, Apple App Store, and Google Play versions of the Clinician CKD Screening app and the patient-centered Kidney Choices app. IPRO’s Clinician CKD Screening and Patient-Centered Kidney Choices apps were designed to:
-Help identify CKD early in at-risk patients and to help manage CKD
-To help delay progression
-To provide kidney replacement information for patients whose CKD has progressed to kidney failure.

To recognize National Kidney Month, the IPRO QIN-QIO launched an educational video series to increase patient health literacy and help patients make informed choices about preventing and managing chronic kidney disease (CKD).

These videos cover important CKD-related topics, including prevention, screening and diagnosis, and management. The series was designed with input from diverse IPRO QIN-QIO Patient and Family Advisory Council members. You are encouraged to share these videos with your patients, residents, and their families. We’ll add more videos soon, so bookmark this page and check back frequently.

The Chronic Kidney Disease Change Package was developed by the National Kidney Foundation (NKF) to assist primary care programs with a systematic approach for transforming CKD care, advancing kidney health equity, and improving health care quality. At the heart of the Change Package is a dashboard of process improvement activities that can be utilized to address CKD screening, recognition, and management. It is intended to serve as a resource from which ambulatory practices can select approaches to build a CKD quality improvement program based on local practice needs and workflows.

This educational guide is intended to foster the development of primary care practice teams to enhance care for vulnerable patients who are at risk of CKD or who have CKD and are at risk of progression of disease or complications. This guide addresses three aspects of care: identification of CKD; treatment and monitoring progression; and delivering patient-centered care. It is meant to inform readers about disparities in the care of patients with CKD, present potential actions that may improve care and suggest other available resources that may be used by primary care practice teams in caring for vulnerable patients.

These are the slides from the presentation on March 2, 2023 featuring Julia Venanzi from CMS and Christine Cordero from the Joint Commission.

This tool was developed by CMS for use by nursing home surveyors and is a valuable resource for organizations that are focusing on preventing ADEs.

It was designed to help surveyors identify:

1. The extent to which facilities have identified resident-specific risk factors for adverse drug events

2. The extent to which facilities developed and implemented systems and processes to minimize risks associated with medications that are known to be high-risk and problem-prone

3. When a preventable adverse event has occurred, evaluate if the nursing home identified the issue and responded appropriately to mitigate harm to the individual and prevent recurrence.

General tips to follow to communicate appropriately and respectfully with and/or about an individual with a disability.